International Development Grant

COVID-19 Vaccine Research and Development

Project Number: CA-3-P009527002

Status: Closed

Country/Region: Unknown

Regional Focus:

Africa 20%
America 20%
Asia 20%
Oceania 20%
Europe 20%

Maximum Contribution: $20,000,000.00

Start Date: January 06, 2021

End Date: December 31, 2021

Duration: 1.0 years

Project Description

This project aims to support the Coalition for Epidemic Preparedness Innovations (CEPI) in developing manufacturing and distributing up to 1.2 billion doses of COVID-19 vaccine(s) and other emerging infectious diseases. This is done through a fair allocation system within 12 to 18 months prioritizing speed scale and access. Project activities include: (1) supporting the research and development of up to 5 vaccine candidates; and (2) supporting the manufacture and distribution of up to 1.2 billion vaccine doses by 2021. This amendment increased Canada’s original contribution under this project to CEPI by $20 Million.

Expected Results

The expected outcomes of this project include: (1) strengthened global preparedness for known epidemic and pandemic threats; (2) strengthened global response to emerging pandemic threats; and (3) improved collaboration between public and private pandemic preparedness and response stakeholders.

Progress & Results Achieved

Results achieved as of 24 May 2022 include: (1) developed 8 COVID-19 vaccine candidates with CEPI support. 7 out of the 8 progressed into Phase II and III clinical trials; (2) supported 3 COVID-19 vaccine candidates (Moderna Astra Zeneca and Novavax) to receive authorization for emergency use by the World Health Organization (WHO); (3) supported 5 candidates to publish primary endpoint analysis of pivotal trial (AZ/Uni Oxford Moderna Novavax CureVac and Clover); and (4) delivered over 900 million COVID-19 vaccine doses in 2021 reaching 95% of its target.

Key Information

Executing Agency:
Coalition for Epidemic Preparedness

Reporting Organization:
Global Affairs Canada

Program:
YFMInternaAssistPartnershp&Programing Br

Last Modified:
September 19, 2025

Development Classifications

DAC Sector:

COVID-19 control 90%
CBRN threat reduction 10%

Aid Type: Core support to NGOs other private bodies PPPs and research institutes

Collaboration: Bilateral core contributions to NGOs and other private bodies / PPPs

Finance Type: Aid grant excluding debt reorganisation

Selection Mechanism:
Department-Initiated

Policy Markers
Level 1 Gender equality
Level 2 Disaster Risk Reduction(DRR)
Major Funding (>$1M)
Budget Breakdown
2020-04-01 to 2021-03-31 $20,000,000 CAD
Geographic Information
000
Project Number: CA-3-P009527002